Innate Pharma advances lacutamab clinical development program

    NEXT STORY
    Continued strong Cresemba® (isavuconazole) sales trigger milestone from Pfizer to Basilea of USD 10 million
    PREV STORY
    GeoVax Announces Pricing of $9.0 Million Bought Deal Offering
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Cesca Therapeutics Announces International Distribution Agreement With Boyalife WSN Ltd.

    RANCHO CORDOVA, Calif., Aug. 24, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a ...

    author_avatar
    NASDAQ Market News

    FDA Approves Myriad’s myChoice® CDx Test to Help Identify Women Eligible for Treatment with Zejula® in Late-line Ovarian Cancer

    author_avatar
    NASDAQ Market News

    DSI Renal Expands Presence in Georgia with New Clinic in Social Circle

    SOCIAL CIRCLE, Ga., July 21, 2015 (GLOBE NEWSWIRE) -- DSI Renal, a leading provider ...

    author_avatar
    NASDAQ Market News